FLGT EBITDA Growth
Fulgent Genetics Inc · EBITDA Growth
FLGT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-83.27%period ending
FLGT TTM EBITDA YoY % (147.05% → -83.27%)
Year-over-year change
High-resolution chart · PNG
FLGT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -83.2662% | |
| -133.4304% | |
| -65.5393% | |
| 53.6183% | |
| -50.6475% | |
| 6.8245% | |
| 20.1889% | |
| -37.5518% | |
| 39.7009% | |
| -305.5321% | |
| -115.6683% | |
| -109.0923% | |
| -107.1215% | |
| -101.0529% | |
| -69.0551% | |
| -48.2292% | |
| -17.624% | |
| 11.8493% | |
| 136.1586% | |
| 1,054.1275% | |
| 16,523.5705% | |
| 34,629.2848% | |
| 17,358.0107% | |
| 6,275.1684% | |
| 414.8585% | |
| 164.4418% | |
| 157.7571% | |
| 125.8909% | |
| 73.2605% | |
| 38.0507% | |
| -65.7355% | |
| -363.8396% | |
| -319.0147% | |
| -229.6013% | |
| -184.0038% | |
| 122.5534% | |
| 143.4313% | |
| 158.6091% | |
| 147.0482% |